Ronald Blue Trust, Inc. Harmony Biosciences Holdings, Inc. Transaction History

Ronald Blue Trust, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$31.86 - $41.49 $1,784 - $2,323	56 Added 19.86%	338 $11,000
Q3 2024 Oct 17, 2024	BUY	$30.0 - $39.95 $5,550 - $7,390	185 Added 190.72%	282 $11,000
Q2 2024 Jul 18, 2024	BUY	$28.81 - $33.01 $2,794 - $3,201	97 New	97 $2,000
Q4 2023 Jan 18, 2024	SELL	$19.2 - $33.78 $3,705 - $6,519	-193 Reduced 88.13%	26 $1,000
Q3 2023 Oct 11, 2023	BUY	$31.89 - $39.03 $6,888 - $8,430	216 Added 7200.0%	219 $8,000
Q2 2023 Jul 14, 2023	BUY	$30.5 - $37.4 $91 - $112	3 New	3 $0

254

46.6M

119K

50K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.19B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.